Announcement under Regulation 30 (LODR)-Press Release / Media Release
Suven Life Sciences presenting at Neuroscience 2018 at San Diego, USA05-11-2018
05-11-2018
Announcement under Regulation 30 (LODR)-Press Release / Media Release
Suven Life Sciences Ltd Announces the last patient enrolled in Phase 2 study of SUVN-502 for Moderate Alzheimer's Disease25-10-2018
Announcement under Regulation 30 (LODR)-Press Release / Media Release
Suven to present at 11TH CLINICAL TRIALS ON ALZHEIMER''S DISEASE (CTAD) during October 24-27, 2018 - BARCELONA, SPAIN23-10-2018
Statement Of Investor Complaints For The Quarter Ended September 2018
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 034340 Name of the Signatory :- K. Hanumantha RaoDesignation :- Company Secretary and Compliance Officer17-10-2018
Submission Of Compliance Certificate Under Regulation 7(3) Of SEBI (LODR) Regulations, 2015 For The Half-Year Ended 30Th September, 2018
With reference to the above subject, please find enclosed compliance certificate for the half-year ended 30th September, 2018 duly signed by the Compliance Officer and authorised representative of the share transfer agent (Karvy Computershare Pvt. Ltd., Hyderabad), under Regulation 7(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 201512-10-2018
Submission Of Compliance Certificate Under Regulation 40(10) For The Half-Year Ended 30Th September, 2018
With reference to above subject, please find enclosed Compliance Certificate for the half-year ended 30th September, 2018 issued by the Practicing Company Secretary, under Regulation 40(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.12-10-2018
Shareholding for the Period Ended September 30, 2018
Suven Life Sciences Ltd has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2018. For more details, kindly Click here11-10-2018
Announcement under Regulation 30 (LODR)-Credit Rating
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015, we wish to intimate you that the CARE Rating has upgraded its ratings of the Company as under:29-09-2018
Company news: Suven Life Sciences
Suven Life Sciences on Tuesday informed the exchanges of the receipt of one product patent from Canada and another from Sri Lanka for the new chemical25-09-2018
Announcement under Regulation 30 (LODR)-Press Release / Media Release
Suven Life Sciences secures Product Patents in Canada and Sri Lanka25-09-2018